These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7813080)
1. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay. Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080 [TBL] [Abstract][Full Text] [Related]
2. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols. Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826 [TBL] [Abstract][Full Text] [Related]
3. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts. Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804 [TBL] [Abstract][Full Text] [Related]
4. [The estrogen receptor/progesterone receptor quotient as an index of the transcriptional activity of estrogen receptors in breast cancer]. Navarro MA; Díez Gibert O; Fernández-Montolí ME; Rosel P; Bonnin MR Med Clin (Barc); 1995 May; 104(18):681-2. PubMed ID: 7769876 [TBL] [Abstract][Full Text] [Related]
5. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method. Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J Oncology; 1994; 51(5):435-9. PubMed ID: 8052485 [TBL] [Abstract][Full Text] [Related]
6. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples. Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay. Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392 [TBL] [Abstract][Full Text] [Related]
8. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study. Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912 [TBL] [Abstract][Full Text] [Related]
9. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors. Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287 [TBL] [Abstract][Full Text] [Related]
10. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods. Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410 [TBL] [Abstract][Full Text] [Related]
11. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347 [TBL] [Abstract][Full Text] [Related]
12. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Blankenstein MA; van der Meulen-Dijk C; Thijssen JH Clin Chim Acta; 1987 Jun; 165(2-3):189-95. PubMed ID: 3308181 [TBL] [Abstract][Full Text] [Related]
13. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma]. Itoh E Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of estrogen and progesterone receptors (ER & PgR) in breast cancer. Fukushima H; Matsuda M; Kawakami H; Kudo A; Kuroki Y; Sakurai M; Shohji T; Nagashima Y; Asami M; Hanaoka T Okajimas Folia Anat Jpn; 1995 Mar; 71(6):365-70. PubMed ID: 7739846 [TBL] [Abstract][Full Text] [Related]
15. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity? Kiang DT; Kollander R J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857 [TBL] [Abstract][Full Text] [Related]
16. Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity. Goussard J Cancer Lett; 1998 Oct; 132(1-2):61-6. PubMed ID: 10397454 [TBL] [Abstract][Full Text] [Related]
17. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay. Dittadi R; Meo S; Amoroso B; Gion M Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273 [TBL] [Abstract][Full Text] [Related]
18. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers. Smyth CM; Benn DE; Reeve TS Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376 [TBL] [Abstract][Full Text] [Related]
19. Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding. Pasic R; Djulbegovic B; Wittliff JL J Clin Lab Anal; 1990; 4(6):430-6. PubMed ID: 2283562 [TBL] [Abstract][Full Text] [Related]
20. Enzyme immunoassay of estrogen and progesterone receptors in drill biopsy specimens from breast cancer. Noguchi S; Miyauchi K; Inaji H; Imaoka S; Koyama H Eur J Cancer Clin Oncol; 1989 May; 25(5):809-14. PubMed ID: 2661238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]